High-purity GHK-Cu is very soluble in bacteriostatic water
28 Overall, we see significant growth opportunities within the GLP-1 category, driven by the expansion of supply to meet the high demand and anticipated approvals for new disease categories.
According to the American Diabetes Association guidelines, GLP-1 receptor agonists are recommended as preferred agents for patients with type 2 diabetes who require weight loss
Most patients lose 8 to 18 pounds during their first 90 days, though results vary based on starting weight, genetics, and lifestyle factors
Patients who can comfortably escalate to their effective dose without cost anxiety tend to progress faster through their weight-loss timeline
Functional medicine practitioners are already exploring its use in recovery protocols, with patient experiences reinforcing its potential